Literature DB >> 6784815

Enterotoxic effect of methotrexate: does it influence the drug's absorption in children with acute lymphoblastic leukaemia?

C R Pinkerton, J F Glasgow, J M Bridges, S G Welshman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6784815      PMCID： PMC1505377          DOI： 10.1136/bmj.282.6272.1276

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia.

Authors:  P J Kearney; P A Light; A Preece; M G Mott
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia.

Authors:  A W Craft; H Kay; D N Lawson; T J McElwain
Journal:  Br Med J       Date:  1977-12-10

3.  Clinical pharmacology of intermediate-dose oral methotrexate.

Authors:  D K Smith; G A Omura; F Ostroy
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333
  3 in total
  10 in total

Review 1.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.

Authors:  Luc J J Derijks; Dennis R Wong; Daniel W Hommes; Adriaan A van Bodegraven
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

2.  Enteropathy complicating maintenance therapy in acute lymphoblastic leukaemia.

Authors:  I J Lewis; D Mainwaring; J Martin
Journal:  Arch Dis Child       Date:  1982-09       Impact factor: 3.791

3.  Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia.

Authors:  A D Pearson; S Mills; H A Amineddine; D R Long; A W Craft; J M Chessells
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  Small bowel function in acute lymphoblastic leukaemia.

Authors:  A D Pearson; A W Craft; J V Pledger; E J Eastham; M F Laker; G L Pearson
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

5.  Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receiving low-dose oral methotrexate.

Authors:  P Sonneveld; F W Schultz; K Nooter; K Hählen
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Topical methotrexate alters solute and water transport in the rat jejunum in vivo and rabbit ileum in vitro.

Authors:  C R Pinkerton; I W Booth; P J Milla
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

7.  Pharmacokinetics of VP16-213 given by different administration methods.

Authors:  M D'Incalci; P Farina; C Sessa; C Mangioni; V Conter; G Masera; M Rocchetti; M B Pisoni; E Piazza; M Beer; F Cavalli
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Small intestinal transit time affects methotrexate absorption in children with acute lymphoblastic leukemia.

Authors:  A D Pearson; A W Craft; E J Eastham; G W Aherne; P Littleton; G L Pearson; A N Campbell
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

9.  The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide.

Authors:  V J Harvey; M L Slevin; S P Joel; A Johnston; P F Wrigley
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

10.  Methotrexate enterotoxicity: influence of drug dose and timing in the rat.

Authors:  C R Pinkerton; P J Milla
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.